Loading
Ana Moreno

Ana Moreno

CEO and Founder, Navega Therapeutics
United States
Ana Moreno received a bachelor’s degree in Biosystems Engineering from the University of Arizona with a focus on biosensors; and master’s and doctorate degrees in Bioengineering from the University of California San Diego with a research focus on epigenome editing via CRISPR-dCas9 and zinc-finger platforms, and was awarded the Engelson award for Best PhD Thesis. Dr. Moreno founded Navega Therapeutics in 2018, a startup developing epigenetic gene therapies for common and complex diseases.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS